Related references
Note: Only part of the references are listed.Validation of the new pathology staging system for progressive supranuclear palsy
Mayen Briggs et al.
ACTA NEUROPATHOLOGICA (2021)
Tau-positron emission tomography correlates with neuropathology findings
Val J. Lowe et al.
ALZHEIMERS & DEMENTIA (2020)
Distribution patterns of tau pathology in progressive supranuclear palsy
Gabor G. Kovacs et al.
ACTA NEUROPATHOLOGICA (2020)
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Adam S. Fleisher et al.
JAMA NEUROLOGY (2020)
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Matthias Brendel et al.
JAMA NEUROLOGY (2020)
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy
Maura Malpetti et al.
ANNALS OF NEUROLOGY (2020)
Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration
Alma Ghirelli et al.
ANNALS OF NEUROLOGY (2020)
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases
David N. Soleimani-Meigooni et al.
BRAIN (2020)
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
Ruben Smith et al.
JAMA NEUROLOGY (2019)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass et al.
NEUROIMAGE (2017)
18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
Daniel R. Schonhaut et al.
ANNALS OF NEUROLOGY (2017)
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marta Marquie et al.
ACTA NEUROPATHOLOGICA (2017)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies
Junchao Tong et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome
David R. Williams et al.
BRAIN (2007)
Share Paper
